AI-Based Clinical Trials Solution Provider Market: Segmented: By Clinical Trial Phase (Phase-I, Phase-II, Phase-III), By Therapeutic Application (Oncology, Cardiovascular Diseases, Neurological Diseases or Conditions, Metabolic Diseases, Infectious Diseases, Others), By End User (Pharmaceutical Companies, Academia, Others), And Region – Global Analysis of Market Size, Share & Trends For 2021–2022 And Forecasts To 2033
Market Overview
The report, AI-Based Clinical Trials Solution Provider Market- Analysis of Market Size, Share & Trends for 2014 - 2022 and Forecasts to 2032, was published by Fatpos Global and is expected to reach Market Value. Fatpos Global conducted a study. The report, in order to provide a thorough understanding of the global market, emphasises the detailed understanding of some key factors, such as size, share, sales, forecast trends, supply, production, demands, industry, and CAGR.
The AI-Based Clinical Trials Solution Provider Market grew from USD 2.56 billion in 2022 to USD 16.0 billion by 3032, exhibiting a CAGR of 18.2% during the forecast period.
Key Companies Profiled
- Deep Lens Inc.
- Hematology-Oncology Associates of CNY
- GlaxoSmithKline plc
- Genentech
- AiCure LLC
- Aiforia
- Antidote Technologies Inc.
- Avantor Inc.
- Deep 6 AI
- Innoplexus Consulting Services Pvt Ltd
- Intelligencia.ai
- MEDIAN Technologies
- Pharmaceutical Pipeline Enhancement Strategies LLC
- Saama Technologies Pvt Ltd
- Simplifai AS
- Other Prominent Players
- By Clinical Trial Phase
- Phase-I
- Phase-II
- Phase-III
- By Therapeutic Application
- Oncology
- Cardiovascular Diseases
- Neurological Diseases or Conditions
- Metabolic Diseases
- Infectious Diseases
- Others
- By End User
- Pharmaceutical Companies
- Academia
- Others
- AI-Based Clinical Trials Solution Provider Market Dynamics
- Size Supply and Demand AI-Based Clinical Trials Solution Provider Market
- Current Issues/Trends/Challenges
- Companies and Competition Market Drivers and Restraints Involved in the Market Value Chain
- The report sheds light on various aspects and provides answers to pertinent market questions. Among the most important are:
- Pre- and post-business impact analysis of COVID-19
- A thorough examination of the parent market
- Market dynamics in the industry are changing.
- Market segmentation in depth
- What is the AI-Based Clinical Trials Solution Provider Market expansion?
- Which segment had the highest AI-Based Clinical Trials Solution Provider Market share?
- Who are the main characters in AI-Based Clinical Trials Solution Provider Market?
- Historical, current, and projected market volumes and values
- Trends and developments in the industry recently
- The competitive environment
- Key players' strategies and products on offer
- Potential and niche segments, as well as geographical regions with promising growth prospects
- A balanced assessment of market performance
- Information that markets participants must have in order to maintain and expand their market footprint.
*Please Note: The report will be delivered in 4-5 business days upon order confirmation*
- 1 Executive Summary
- 2 Global AI-Based Clinical Trials Solution Provider Market
- 2.1. Product Overview
- 2.2. Market Definition
- 2.3. Segmentation
- 2.4. Assumptions and Acronyms
- 3 Research Methodology
- 3.1. Research Objectives
- 3.2. Primary Research
- 3.3. Secondary Research
- 3.4. Forecast Model
- 3.5. Market Size Estimation
- 4 Average Pricing Analysis
- 5 Macro-Economic Indicators
- 6 Market Dynamics
- 6.1. Growth Drivers
- 6.2. Restraints
- 6.3. Opportunity
- 6.4. Trends
- 7 Correlation & Regression Analysis
- 7.1. Correlation Matrix
- 7.2. Regression Matrix
- 8 Recent Development, Policies & Regulatory Landscape
- 9 Risk Analysis
- 9.1. Demand Risk Analysis
- 9.2. Supply Risk Analysis
- 10 Global AI-Based Clinical Trials Solution Provider Market Analysis
- 10.1. Porters Five Forces
- 10.1.1. Threat of New Entrants
- 10.1.2. Bargaining Power of Suppliers
- 10.1.3. Threat of Substitutes
- 10.1.4. Rivalry
- 10.2. PEST Analysis
- 10.2.1. Political
- 10.2.2. Economic
- 10.2.3. Social
- 10.2.4. Technological
- 11 Global AI-Based Clinical Trials Solution Provider Market
- 11.1. Market Size & forecast, 2020A-2030F
- 11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12 Global Oncology Pharmaceuticals Market: Market Segmentation
- 12.1. By Regions
- 12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.2. By Type: Market Share (2020-2030F)
- 12.2.1. Chemotherapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.2.2. Targeted Therapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.2.3. Immunotherapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.2.4. Hormonal Therapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3. By Indication: Market Share (2020-2030F)
- 12.3.1. Lung Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3.2. Stomach Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3.3. Breast Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3.4. Prostate Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3.5. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.4. By End user: Market Share (2020-2030F)
- 12.4.1. Specialized cancer treatment centers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.4.2. Hospitals Pharmacies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.4.3. Retail Pharmacies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 13 Company Profile
- Deep Lens Inc.
- Hematology-Oncology Associates of CNY
- GlaxoSmithKline plc
- Genentech
- AiCure LLC
- Aiforia
- Antidote Technologies Inc.
- Avantor Inc.
- Deep 6 AI
- Innoplexus Consulting Services Pvt Ltd
- Intelligencia.ai
- MEDIAN Technologies
- Pharmaceutical Pipeline Enhancement Strategies LLC
- Saama Technologies Pvt Ltd
- Simplifai AS
- Other Prominent Players
- 14 Consultant Recommendation
- **The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook